These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 32800789)
41. Pharmacological Activity of Cepharanthine. Liu K; Hong B; Wang S; Lou F; You Y; Hu R; Shafqat A; Fan H; Tong Y Molecules; 2023 Jun; 28(13):. PubMed ID: 37446681 [TBL] [Abstract][Full Text] [Related]
42. Tetrandrine induces G1/S cell cycle arrest through the ROS/Akt pathway in EOMA cells and inhibits angiogenesis in vivo. Xiao W; Jiang Y; Men Q; Yuan L; Huang Z; Liu T; Li W; Liu X Int J Oncol; 2015 Jan; 46(1):360-8. PubMed ID: 25355542 [TBL] [Abstract][Full Text] [Related]
44. Tetrandrine inhibits signal-induced NF-kappa B activation in rat alveolar macrophages. Chen F; Sun S; Kuhn DC; Lu Y; Gaydos LJ; Shi X; Demers LM Biochem Biophys Res Commun; 1997 Feb; 231(1):99-102. PubMed ID: 9070227 [TBL] [Abstract][Full Text] [Related]
45. The dual specificity PI3K/mTOR inhibitor PKI-587 displays efficacy against T-cell acute lymphoblastic leukemia (T-ALL). Gazi M; Moharram SA; Marhäll A; Kazi JU Cancer Lett; 2017 Apr; 392():9-16. PubMed ID: 28159681 [TBL] [Abstract][Full Text] [Related]
46. Tetrandrine inhibits colon carcinoma HT-29 cells growth via the Bcl-2/Caspase 3/PARP pathway and G1/S phase. Li J; Wang Q; Wang Z; Cui N; Yang B; Niu W; Kuang H Biosci Rep; 2019 May; 39(5):. PubMed ID: 31040202 [TBL] [Abstract][Full Text] [Related]
47. Harnessing the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia: eliminating activity by targeting at different levels. Bressanin D; Evangelisti C; Ricci F; Tabellini G; Chiarini F; Tazzari PL; Melchionda F; Buontempo F; Pagliaro P; Pession A; McCubrey JA; Martelli AM Oncotarget; 2012 Aug; 3(8):811-23. PubMed ID: 22885370 [TBL] [Abstract][Full Text] [Related]
48. Potent inhibition of HIV type 1 replication by an antiinflammatory alkaloid, cepharanthine, in chronically infected monocytic cells. Okamoto M; Ono M; Baba M AIDS Res Hum Retroviruses; 1998 Sep; 14(14):1239-45. PubMed ID: 9764907 [TBL] [Abstract][Full Text] [Related]
49. Silymarin inhibits cell cycle progression and mTOR activity in activated human T cells: therapeutic implications for autoimmune diseases. Gharagozloo M; Javid EN; Rezaei A; Mousavizadeh K Basic Clin Pharmacol Toxicol; 2013 Apr; 112(4):251-6. PubMed ID: 23121838 [TBL] [Abstract][Full Text] [Related]
50. Fangchinoline, a Bisbenzylisoquinoline Alkaloid can Modulate Cytokine-Impelled Apoptosis via the Dual Regulation of NF-κB and AP-1 Pathways. Jung YY; Shanmugam MK; Chinnathambi A; Alharbi SA; Shair OHM; Um JY; Sethi G; Ahn KS Molecules; 2019 Aug; 24(17):. PubMed ID: 31466313 [TBL] [Abstract][Full Text] [Related]
52. [P38 mitogen-activated protein kinase mediates glucocorticoid receptor function induced by dexamethasone in acute lymphoblastic leukemia cells]. He L; Li D; Hou KZ; Liu YP Zhonghua Er Ke Za Zhi; 2007 Sep; 45(9):687-91. PubMed ID: 18021564 [TBL] [Abstract][Full Text] [Related]
53. Thirteen bisbenzylisoquinoline alkaloids in five Chinese medicinal plants: Botany, traditional uses, phytochemistry, pharmacokinetic and toxicity studies. Zhang H; Wang X; Guo Y; Liu X; Zhao X; Teka T; Lv C; Han L; Huang Y; Pan G J Ethnopharmacol; 2021 Mar; 268():113566. PubMed ID: 33166629 [TBL] [Abstract][Full Text] [Related]
54. Low-dose anisomycin sensitizes glucocorticoid-resistant T-acute lymphoblastic leukemia CEM-C1 cells to dexamethasone-induced apoptosis through activation of glucocorticoid receptor and p38-MAPK/JNK. Liu Y; Ge J; Li Q; Guo X; Gu L; Ma ZG; Li XH; Zhu YP Leuk Lymphoma; 2014 Sep; 55(9):2179-88. PubMed ID: 24597985 [TBL] [Abstract][Full Text] [Related]
55. Targeting of active mTOR inhibits primary leukemia T cells and synergizes with cytotoxic drugs and signaling inhibitors. Batista A; Barata JT; Raderschall E; Sallan SE; Carlesso N; Nadler LM; Cardoso AA Exp Hematol; 2011 Apr; 39(4):457-472.e3. PubMed ID: 21277936 [TBL] [Abstract][Full Text] [Related]
56. Tetrandrine induces apoptosis by activating reactive oxygen species and repressing Akt activity in human hepatocellular carcinoma. Liu C; Gong K; Mao X; Li W Int J Cancer; 2011 Sep; 129(6):1519-31. PubMed ID: 21128229 [TBL] [Abstract][Full Text] [Related]
57. Tetrandrine prevents acquired drug resistance of K562 cells through inhibition of mdr1 gene transcription. Shen H; Xu W; Chen Q; Wu Z; Tang H; Wang F J Cancer Res Clin Oncol; 2010 May; 136(5):659-65. PubMed ID: 19898868 [TBL] [Abstract][Full Text] [Related]
58. Tetrandrine induces apoptosis Via caspase-8, -9, and -3 and poly (ADP ribose) polymerase dependent pathways and autophagy through beclin-1/ LC3-I, II signaling pathways in human oral cancer HSC-3 cells. Yu FS; Yu CS; Chen JC; Yang JL; Lu HF; Chang SJ; Lin MW; Chung JG Environ Toxicol; 2016 Apr; 31(4):395-406. PubMed ID: 25266202 [TBL] [Abstract][Full Text] [Related]
59. Activity of the novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 against T-cell acute lymphoblastic leukemia. Chiarini F; Grimaldi C; Ricci F; Tazzari PL; Evangelisti C; Ognibene A; Battistelli M; Falcieri E; Melchionda F; Pession A; Pagliaro P; McCubrey JA; Martelli AM Cancer Res; 2010 Oct; 70(20):8097-107. PubMed ID: 20876803 [TBL] [Abstract][Full Text] [Related]
60. Tetrandrine blocks cardiac hypertrophy by disrupting reactive oxygen species-dependent ERK1/2 signalling. Shen DF; Tang QZ; Yan L; Zhang Y; Zhu LH; Wang L; Liu C; Bian ZY; Li H Br J Pharmacol; 2010 Feb; 159(4):970-81. PubMed ID: 20105174 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]